Neurosense Financial Statements From 2010 to 2025
| NRSN Stock | | | USD 1.74 0.11 5.95% |
Neurosense Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neurosense Therapeutics' valuation are provided below:
Market Capitalization | Earnings Share |
We have found one hundred twenty available fundamental ratios for Neurosense Therapeutics, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Neurosense Therapeutics' last-minute
fundamentals against the trend between
2010 and 2025 to make sure the company can sustain itself down the road. As of the 30th of July 2025,
Market Cap is likely to grow to about 21.1
M. Also,
Enterprise Value is likely to grow to about 18
MCheck out the analysis of
Neurosense Therapeutics Correlation against competitors.
To learn how to invest in Neurosense Stock, please use our
How to Invest in Neurosense Therapeutics guide.
Neurosense Therapeutics Balance Sheet | | |
|
Neurosense Therapeutics Income Statement | | |
|
Neurosense Therapeutics Cash Flow Statement | | |
|
Financial Ratios | | |
|
Neurosense Therapeutics Valuation Data | | |
| Current Value | Last Year | Historical Average | 10 Year Trend |
|---|
| Market Cap | 21.1 M | 20.1 M | 10.5 M | |
|
Neurosense Fundamental Market Drivers
| Cash And Short Term Investments | 3.4 M |
Neurosense Upcoming Events
About Neurosense Therapeutics Financial Statements
Neurosense Therapeutics investors utilize fundamental indicators, such as revenue or net income, to predict how Neurosense Stock might perform in the future. Analyzing these trends over time helps investors make informed
market timing decisions. For further insights, please visit our
fundamental analysis page.
Pair Trading with Neurosense Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neurosense Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Neurosense Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neurosense Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neurosense Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neurosense Therapeutics to buy it.
The correlation of Neurosense Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurosense Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurosense Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neurosense Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
When determining whether Neurosense Therapeutics
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurosense Therapeutics'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurosense Therapeutics Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Neurosense Therapeutics Stock: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets | Return On Equity |
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.